Standard BioTools Pre-Tax Profit Margin 2011-2025 | LAB
Standard BioTools pre-tax profit margin from 2011 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Standard BioTools Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $0.17B | $-0.14B | -81.44% |
| 2025-06-30 | $0.17B | $-0.13B | -73.96% |
| 2025-03-31 | $0.17B | $-0.13B | -78.11% |
| 2024-12-31 | $0.17B | $-0.14B | -79.31% |
| 2024-09-30 | $0.12B | $-0.10B | -83.90% |
| 2024-06-30 | $0.12B | $-0.10B | -80.99% |
| 2024-03-31 | $0.13B | $-0.09B | -70.87% |
| 2023-12-31 | $0.11B | $-0.08B | -70.75% |
| 2023-09-30 | $0.11B | $-0.08B | -72.38% |
| 2023-06-30 | $0.11B | $-0.09B | -80.19% |
| 2023-03-31 | $0.10B | $-0.13B | -137.11% |
| 2022-12-31 | $0.10B | $-0.19B | -194.95% |
| 2022-09-30 | $0.11B | $-0.18B | -165.45% |
| 2022-06-30 | $0.11B | $-0.17B | -147.79% |
| 2022-03-31 | $0.13B | $-0.12B | -96.00% |
| 2021-12-31 | $0.13B | $-0.06B | -48.09% |
| 2021-09-30 | $0.14B | $-0.07B | -50.72% |
| 2021-06-30 | $0.15B | $-0.06B | -40.94% |
| 2021-03-31 | $0.14B | $-0.06B | -39.58% |
| 2020-12-31 | $0.14B | $-0.05B | -38.85% |
| 2020-09-30 | $0.13B | $-0.05B | -38.89% |
| 2020-06-30 | $0.11B | $-0.06B | -50.89% |
| 2020-03-31 | $0.11B | $-0.06B | -50.88% |
| 2019-12-31 | $0.12B | $-0.07B | -56.90% |
| 2019-09-30 | $0.12B | $-0.07B | -59.48% |
| 2019-06-30 | $0.12B | $-0.07B | -59.66% |
| 2019-03-31 | $0.12B | $-0.07B | -61.54% |
| 2018-12-31 | $0.11B | $-0.06B | -54.46% |
| 2018-09-30 | $0.11B | $-0.06B | -51.85% |
| 2018-06-30 | $0.10B | $-0.06B | -54.81% |
| 2018-03-31 | $0.10B | $-0.06B | -57.84% |
| 2017-12-31 | $0.10B | $-0.06B | -62.14% |
| 2017-09-30 | $0.10B | $-0.07B | -74.00% |
| 2017-06-30 | $0.10B | $-0.08B | -79.38% |
| 2017-03-31 | $0.10B | $-0.08B | -78.22% |
| 2016-12-31 | $0.10B | $-0.08B | -77.88% |
| 2016-09-30 | $0.11B | $-0.07B | -67.27% |
| 2016-06-30 | $0.12B | $-0.06B | -54.70% |
| 2016-03-31 | $0.12B | $-0.06B | -50.85% |
| 2015-12-31 | $0.12B | $-0.06B | -48.28% |
| 2015-09-30 | $0.12B | $-0.06B | -46.61% |
| 2015-06-30 | $0.12B | $-0.06B | -50.42% |
| 2015-03-31 | $0.12B | $-0.06B | -49.15% |
| 2014-12-31 | $0.12B | $-0.06B | -50.43% |
| 2014-09-30 | $0.11B | $-0.05B | -49.52% |
| 2014-06-30 | $0.09B | $-0.04B | -44.09% |
| 2014-03-31 | $0.08B | $-0.03B | -37.80% |
| 2013-12-31 | $0.07B | $-0.02B | -23.94% |
| 2013-09-30 | $0.07B | $-0.02B | -24.24% |
| 2013-06-30 | $0.06B | $-0.02B | -26.23% |
| 2013-03-31 | $0.06B | $-0.02B | -29.82% |
| 2012-12-31 | $0.05B | $-0.02B | -37.74% |
| 2012-09-30 | $0.05B | $-0.02B | -38.00% |
| 2012-06-30 | $0.05B | $-0.02B | -39.58% |
| 2012-03-31 | $0.05B | $-0.02B | -45.65% |
| 2011-12-31 | $0.04B | $-0.02B | -47.73% |
| 2011-09-30 | $0.04B | $-0.02B | -51.22% |
| 2011-06-30 | $0.04B | $-0.02B | -52.63% |
| 2011-03-31 | $0.04B | $-0.02B | -51.43% |
| 2010-12-31 | $0.03B | $-0.02B | -51.52% |
| 2010-06-30 | $0.02B | $-0.02B | -100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.438B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.395B | 59.05 |
| Tempus AI (TEM) | United States | $14.291B | 0.00 |
| Doximity (DOCS) | United States | $11.985B | 53.33 |
| Hims & Hers Health (HIMS) | United States | $9.884B | 76.72 |
| IRhythm Technologies (IRTC) | United States | $5.815B | 0.00 |
| Hinge Health (HNGE) | United States | $3.560B | 0.00 |
| Privia Health (PRVA) | United States | $3.071B | 227.46 |
| Heartflow (HTFL) | United States | $2.895B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.406B | 39.82 |
| Enovis (ENOV) | United States | $1.800B | 9.51 |
| 10x Genomics (TXG) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.642B | 32.79 |
| Clover Health Investments (CLOV) | United States | $1.520B | 0.00 |
| Schrodinger (SDGR) | United States | $1.455B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Phreesia (PHR) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.071B | 0.00 |
| Evolent Health (EVH) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.697B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.632B | 0.00 |
| Talkspace (TALK) | United States | $0.576B | 114.67 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.505B | 0.00 |
| Carlsmed (CARL) | United States | $0.322B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.290B | 50.76 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.223B | 0.00 |
| Outset Medical (OM) | United States | $0.223B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.186B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 5.67 |
| EUDA Health Holdings (EUDA) | Singapore | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.074B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| 111 (YI) | China | $0.038B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.027B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |